Gabriel Cerrone - Net Worth and Insider Trading

Gabriel Cerrone Net Worth

The estimated net worth of Gabriel Cerrone is at least $45,657 dollars as of 2024-04-26. Gabriel Cerrone is the Director of Cardiff Oncology Inc and owns about 9,525 shares of Cardiff Oncology Inc (CRDF) stock worth over $38,576. Gabriel Cerrone is also the Former Director of Synergy Pharmaceuticals Inc and owns about 1,106,343 shares of Synergy Pharmaceuticals Inc (SGYPQ) stock worth over $7,081. Details can be seen in Gabriel Cerrone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gabriel Cerrone has not made any transactions after 2013-10-29 and currently still holds the listed stock(s).

Transaction Summary of Gabriel Cerrone

To

Gabriel Cerrone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gabriel Cerrone owns 2 companies in total, including Cardiff Oncology Inc (CRDF) , and Hepion Pharmaceuticals Inc (HEPA) .

Click here to see the complete history of Gabriel Cerrone’s form 4 insider trades.

Insider Ownership Summary of Gabriel Cerrone

Ticker Comapny Transaction Date Type of Owner
CRDF Cardiff Oncology Inc 2012-08-20 director & 10 percent owner
HEPA Hepion Pharmaceuticals Inc 2016-08-17 10 percent owner

Gabriel Cerrone Latest Holdings Summary

Gabriel Cerrone currently owns a total of 2 stocks. Among these stocks, Gabriel Cerrone owns 9,525 shares of Cardiff Oncology Inc (CRDF) as of August 20, 2012, with a value of $38,576 and a weighting of 84.49%. Gabriel Cerrone also owns 1,106,343 shares of Synergy Pharmaceuticals Inc (SGYPQ) as of October 29, 2013, with a value of $7,081 and a weighting of 15.51%.

Latest Holdings of Gabriel Cerrone

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRDF Cardiff Oncology Inc 2012-08-20 9,525 4.05 38,576
SGYPQ Synergy Pharmaceuticals Inc 2013-10-29 1,106,343 0.01 7,081

Holding Weightings of Gabriel Cerrone


Gabriel Cerrone Form 4 Trading Tracker

According to the SEC Form 4 filings, Gabriel Cerrone has made a total of 0 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years. The most-recent trade in Cardiff Oncology Inc is the acquisition of 108 shares on August 20, 2012, which cost Gabriel Cerrone around $18,330.

According to the SEC Form 4 filings, Gabriel Cerrone has made a total of 0 transactions in Synergy Pharmaceuticals Inc (SGYPQ) over the past 5 years. The most-recent trade in Synergy Pharmaceuticals Inc is the acquisition of 12,000 shares on October 29, 2013, which cost Gabriel Cerrone around $49,080.

Insider Trading History of Gabriel Cerrone

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gabriel Cerrone Trading Performance

GuruFocus tracks the stock performance after each of Gabriel Cerrone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gabriel Cerrone is 14.61%. GuruFocus also compares Gabriel Cerrone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gabriel Cerrone within 3 months outperforms 4 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gabriel Cerrone's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gabriel Cerrone

Average Return

46.35%

Average return per transaction

Outperforming Transactions

55%

6 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.44 14.61 31.21 46.35 -1.17 4.02
Relative Return to S&P 500(%) 7.83 10.63 20.61 27.88 -17.21 -6.49

Gabriel Cerrone Ownership Network

Ownership Network List of Gabriel Cerrone

No Data

Ownership Network Relation of Gabriel Cerrone


Gabriel Cerrone Owned Company Details

What does Cardiff Oncology Inc do?

Who are the key executives at Cardiff Oncology Inc?

Gabriel Cerrone is the director & 10 percent owner of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .

Cardiff Oncology Inc (CRDF) Insider Trades Summary

Over the past 18 months, Gabriel Cerrone made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace , and a net purchase of 10,000 shares made by Mark Erlander .

In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 62,950 shares were bought by its insiders, resulting in a net purchase of 62,950 shares.

Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cardiff Oncology Inc Insider Transactions

No Available Data

Gabriel Cerrone Mailing Address

Above is the net worth, insider trading, and ownership report for Gabriel Cerrone. You might contact Gabriel Cerrone via mailing address: Via Sant' Andrea 18, Milan L6 20121.

Discussions on Gabriel Cerrone

No discussions yet.